Quote this publication Share Print


Opinions on drugs - Posted on Mar 19 2013

Reason for request

Re-assessment of the Actual Benefit and Improvement in Actual Benefit in accordance with article R-163-21 of the Social Security Code.


Clinical Benefit


The actual benefit of ABILIFY in the treatment of schizophrenia remains substantial.

Clinical Added Value


ABILIFY, like all other antipsychotics (including typical antipsychotics), provides a moderate improvement in actual benefit (IAB III) to the management of schizophrenia.

Contact Us

Évaluation des médicaments

See also